46-60 of 516
Evaluating Biologic Therapy Response in Severe Asthma Care
Clinician's RoundtableEvaluating Biologic Therapy Response in Severe Asthma Care
Charles Turck, PharmD, BCPS, BCCCP
Sara Assaf, MD
Navigating NTM Lung Disease: A Patient-Centered Approach
Clinician's RoundtableNavigating NTM Lung Disease: A Patient-Centered Approach
Charles Turck, PharmD, BCPS, BCCCP
Kenneth Olivier, MD, MPH
Shelby MacRae, MD
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Project Oncology®6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Steve Jackson, PharmD
Lyudmila A. Bazhenova, MD
Assessing and Interpreting pCR in Perioperative NSCLC
Project Oncology®Assessing and Interpreting pCR in Perioperative NSCLC
Steve Jackson, PharmD
Alexander Spira, MD, PhD, FACP
Key Differences in Pulmonary and Extrapulmonary NEC Management
Project Oncology®Key Differences in Pulmonary and Extrapulmonary NEC Management
Alexandria May, PharmD, BCPS
Lowell B. Anthony, MD, FACP
The Growing Role of Digital Inhalers in Asthma
Clinician's RoundtableThe Growing Role of Digital Inhalers in Asthma
Marcus Shaker, MD, MSc, FAAP, FACAAI, FAAAAI
- advertisement
Making Asthma Care Simpler with SMART Therapy
Clinician's RoundtableMaking Asthma Care Simpler with SMART Therapy
Marcus Shaker, MD, MSc, FAAP, FACAAI, FAAAAI
Access to Care Shouldn’t Limit Asthma Outcomes: An Expert's Perspective
Clinician's RoundtableAccess to Care Shouldn’t Limit Asthma Outcomes: An Expert's Perspective
Marcus Shaker, MD, MSc, FAAP, FACAAI, FAAAAI
How Precision Medicine Is Transforming Asthma Care
Clinician's RoundtableHow Precision Medicine Is Transforming Asthma Care
Sally E. Wenzel, MD, ATSF
Understanding the Many Drivers of Severe Asthma
Clinician's RoundtableUnderstanding the Many Drivers of Severe Asthma
Sally E. Wenzel, MD, ATSF
Managing Immunotherapy Toxicities in Lung Cancer Patients
Spotlight on Lung CancerManaging Immunotherapy Toxicities in Lung Cancer Patients
Jacob Sands, MD
Aliyah Pabani, MD
Communicating Pathologic Response Results in Resectable NSCLC
Project Oncology®Communicating Pathologic Response Results in Resectable NSCLC
Charles Turck, PharmD, BCPS, BCCCP
Alexander Spira, MD, PhD, FACP
Robert Merritt, MD
- advertisement
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP
Deepa Rangachari, MD
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®Managing Immune-Related Adverse Events in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP
Paul Bunn, MD
Managing High-Risk Subgroups in Metastatic NSCLC
Project Oncology®Managing High-Risk Subgroups in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP
Melina Marmarelis, MD
Deepa Rangachari, MD
